Source: International Congress 2015 – Sarcoidosis: clinical
Disease area: Interstitial lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Alexander Vizel (Kazan, Russian Federation), Irina Vizel, Alexander Vizel. Methotrexate as a single agent for the treatment of patients with progressive pulmonary sarcoidosis. Eur Respir J 2015; 46: Suppl. 59, 843

Member's Comments

No comment yet.

Related content which might interest you: Are there any predictors of MTX response in progressive pulmonary sarcoidosis? Source: International Congress 2015 – Acute and chronic lung diseases: good clinical practice Year: 2015 TNF-α polymorphism as a prognostic marker for MTX efficacy in progressive pulmonary sarcoidosis Source: International Congress 2016 – Sarcoidosis Year: 2016 Methotrexate (MTX) as a single agent for treating chronic, progressive sarcoidosis Source: International Congress 2014 – Sarcoidosis Year: 2014 Efficacy of adalimumab in sarcoidosis patients who developed intolerance to infliximab Source: International Congress 2016 – Sarcoidosis Year: 2016 Infliximab: An effective rescue therapy in refractory extra-pulmonary sarcoidosis Source: Annual Congress 2013 –Sarcoidosis and other granulomatosis Year: 2013 Unusual multisystemic relapse of sarcoidosis after corticosteroids withdrawal Source: Annual Congress 2013 –Diffuse parenchymal lung disease III Year: 2013 Corticosteroid treatment in sarcoidosis Source: Eur Respir J 2006; 28: 627-636 Year: 2006 Lymphangioma in patients with pulmonary lymphangioleiomyomatosis – Results of sirolimus treatment Source: International Congress 2016 – Orphan diseases I Year: 2016 Sarcoidosis Source: Respipedia Article Year: 2017 Anti-inflammatory therapy for sarcoidosis patients Source: Annual Congress 2013 –Diffuse parenchymal lung disease III Year: 2013 Role of infliximab in managing resistant ventricular arrhythmias in sarcoidosis Source: International Congress 2015 – Sarcoidosis: clinical Year: 2015 Methotrexate in the treatment of the chronic form of pulmonary and extra - pulmonary sarcoidosis Source: Eur Respir J 2004; 24: Suppl. 48, 712s Year: 2004 Treatment with low-dose everolimus in patients with sporadic lymphangioleiomyomatosis (LAM) Source: International Congress 2014 – New treatments for cough, asthma, COPD and ILDs Year: 2014 Clinical experience with pirfenidone for the treatment of idiopathic pulmonary fibrosis Source: Annual Congress 2013 –Diffuse parenchymal lung disease III Year: 2013 Markers of resistance to corticosteroids therapy in patients with pulmonary sarcoidosis Source: Virtual Congress 2020 – Genetics and biomarkers for diagnosis and prognosis of granulomatous lung diseases Year: 2020 How many patients require corticosteroid treatment in sarcoidosis? – Preliminary study Source: International Congress 2014 – Sarcoidosis Year: 2014 Sarcoidosis relapses in corticosteroid treated patients Source: Annual Congress 2012 - Novelties in clinical management of thoracic diseases: from diaphragm to pleura Year: 2012 Infliximab in patients with refractory sarcoidosis: Trough concentrations of infiximab Source: International Congress 2015 – Clinical problems in acute and chronic lung diseases Year: 2015 Steroid treatment effect in pulmonary sarcoidosis (STEPS study) Source: International Congress 2015 – Sarcoidosis: clinical Year: 2015 Rituximab in the treatment of refractory pulmonary sarcoidosis Source: Eur Respir J 2014; 43: 1525-1528 Year: 2014